Nimotuzumab

WikiDoc Resources for Nimotuzumab
Articles
Most recent articles on Nimotuzumab Most cited articles on Nimotuzumab Review articles on Nimotuzumab Articles on Nimotuzumab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Nimotuzumab Images of Nimotuzumab Photos of Nimotuzumab Podcasts & MP3s on Nimotuzumab Videos on Nimotuzumab
Evidence Based Medicine
Cochrane Collaboration on Nimotuzumab Bandolier on Nimotuzumab TRIP on Nimotuzumab
Clinical Trials
Ongoing Trials on Nimotuzumab at Clinical Trials.gov Trial results on Nimotuzumab Clinical Trials on Nimotuzumab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Nimotuzumab NICE Guidance on Nimotuzumab NHS PRODIGY Guidance FDA on Nimotuzumab CDC on Nimotuzumab
Books
Books on Nimotuzumab
News
Nimotuzumab in the news Be alerted to news on Nimotuzumab News trends on Nimotuzumab
Commentary
Blogs on Nimotuzumab
Definitions
Definitions of Nimotuzumab
Patient Resources / Community
Patient resources on Nimotuzumab Discussion groups on Nimotuzumab Patient Handouts on Nimotuzumab Directions to Hospitals Treating Nimotuzumab Risk calculators and risk factors for Nimotuzumab
Healthcare Provider Resources
Symptoms of Nimotuzumab Causes & Risk Factors for Nimotuzumab Diagnostic studies for Nimotuzumab Treatment of Nimotuzumab
Continuing Medical Education (CME)
CME Programs on Nimotuzumab
International
Nimotuzumab en Espanol Nimotuzumab en Francais
Business
Nimotuzumab in the Marketplace Patents on Nimotuzumab
Experimental / Informatics
List of terms related to Nimotuzumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Nimotuzumab is a humanized monoclonal antibody used to treat cancer. It binds to EGFR (epithelial growth factor receptor).